HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Kojima Selected Research

fucoxanthinol

7/2022Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol.
1/2022A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
5/2021Fucoxanthin and Colorectal Cancer Prevention.
5/2021Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from an N-Nitrosobis(2-oxopropyl)amine-initiated Syrian Golden Hamster Pancreatic Carcinogenesis Model.
3/2021A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell.
1/2021Effects of CLIC4 on Fucoxanthinol-Induced Apoptosis in Human Colorectal Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Kojima Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 10/2005
7Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 12/2019
7Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 11/2019
6Pain (Aches)
06/2013 - 06/2004
5Inflammation (Inflammations)
01/2022 - 01/2013
5Carcinogenesis
01/2022 - 11/2009
4Hemorrhage
09/2022 - 07/2021
4Pathologic Constriction (Stenosis)
04/2022 - 09/2004
4Adenocarcinoma
01/2022 - 12/2019
4Compression Fractures (Compression Fracture)
03/2008 - 01/2006
3Colonic Neoplasms (Colon Cancer)
01/2022 - 12/2019
3Asthma (Bronchial Asthma)
01/2017 - 10/2005
2Acute Kidney Injury (Acute Renal Failure)
10/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2021 - 05/2009
2Lymphoma (Lymphomas)
03/2015 - 03/2012
2Cancer Pain
06/2013 - 05/2011
2Neuralgia (Stump Neuralgia)
09/2012 - 06/2004
2Neoplasm Metastasis (Metastasis)
11/2009 - 02/2006
1Adenoma (Adenomas)
11/2022
1Afferent Loop Syndrome
07/2022
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2022
1Obstructive Jaundice (Cholestatic Jaundice)
06/2022
1Fecal Incontinence
01/2022
1Cognitive Dysfunction
01/2022
1Neglected Diseases
01/2022
1Leishmaniasis
01/2022
1Schistosomiasis (Bilharziasis)
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Chagas Disease (American Trypanosomiasis)
01/2022
1Cholecystitis
07/2021
1Fever (Fevers)
04/2021
1Alzheimer Disease (Alzheimer's Disease)
02/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2021
1Mucinous Cystadenoma
01/2021

Drug/Important Bio-Agent (IBA)

11fucoxanthinIBA
01/2022 - 12/2019
7Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2003
6fucoxanthinolIBA
07/2022 - 01/2021
6Carotenoids (Carotene)IBA
07/2022 - 12/2019
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2022 - 12/2019
4AzoxymethaneIBA
01/2022 - 12/2019
3ChloridesIBA
07/2022 - 01/2021
3Dextrans (Dextran)FDA Link
01/2022 - 11/2020
2Peptides (Polypeptides)IBA
09/2022 - 10/2021
2CC ChemokinesIBA
01/2022 - 12/2021
2Pharmaceutical PreparationsIBA
01/2022 - 01/2022
2Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2013
2LigandsIBA
01/2022 - 12/2021
2Interleukin-17 (Interleukin 17)IBA
01/2017 - 03/2012
2InterleukinsIBA
01/2017 - 10/2015
2IonomycinIBA
03/2015 - 03/2012
2Tetradecanoylphorbol AcetateIBA
03/2015 - 03/2012
2Messenger RNA (mRNA)IBA
03/2015 - 03/2012
2Fentanyl (Sublimaze)FDA LinkGeneric
06/2013 - 05/2011
2Analgesics (Analgesic Drugs)IBA
09/2012 - 01/2006
2Carbon DioxideIBA
11/2010 - 10/2005
1HydrogelsIBA
09/2022
1Hemostatics (Antihemorrhagics)IBA
09/2022
1MetalsIBA
06/2022
1XanthophyllsIBA
01/2022
1Praziquantel (Biltricide)FDA Link
01/2022
1Scopolamine (Hyoscine)FDA Link
01/2022
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2022
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2022
1Neuroprotective AgentsIBA
01/2022
1Delayed-Action PreparationsIBA
01/2022
1Testosterone (Sustanon)FDA Link
01/2022
1Small Interfering RNA (siRNA)IBA
12/2021
1Chemokine CCL21IBA
12/2021
1Cadherins (E-Cadherin)IBA
12/2021
1Therapeutic UsesIBA
11/2021
1N-acetyltalosaminuronic acid (NAT)IBA
11/2021
1AnionsIBA
10/2021
1Hydrolyzable TanninsIBA
06/2021
1RNA (Ribonucleic Acid)IBA
06/2021
1casuarictinIBA
06/2021
1strictininIBA
06/2021
1nitrosobis(2-oxopropyl)amine (NBOP)IBA
05/2021
1Anti-Bacterial Agents (Antibiotics)IBA
04/2021
1asaroneIBA
02/2021
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021

Therapy/Procedure

6Therapeutics
11/2022 - 02/2006
5Stents
06/2022 - 09/2004
5Vertebroplasty
03/2008 - 01/2006
4Radiofrequency Ablation
11/2022 - 11/2004
3Drug Therapy (Chemotherapy)
11/2021 - 05/2009
2Endoscopic Sphincterotomy
09/2022 - 06/2022
2Chemoprevention
01/2022 - 12/2021
2Oral Administration
01/2022 - 01/2021
2Extracorporeal Shockwave Therapy
11/2021 - 11/2019
2Pancreatectomy
01/2021 - 09/2004
2Radiotherapy
11/2009 - 11/2006
2Renal Dialysis (Hemodialysis)
05/2007 - 02/2005
1Endoscopic Hemostasis
09/2022
1Operative Surgical Procedures
09/2022
1Gastric Bypass (Roux-en-Y Gastric Bypass)
07/2022
1Decompression
07/2022
1Microspheres (Microsphere)
01/2022
1Transplantation
12/2021
1Blood Transfusion (Blood Transfusions)
07/2021
1Conservative Treatment
07/2021